This week in cardiology from heartwire
View all posts »#114: Cardiologist, are you fat, unfit, unmotivated?; BP meds more effective at night; FDA advisors recommend Vytorin; fludrocortisone flops for vasovagal syncope; FDA recommends Sapien valve
Nov 4, 2011 15:45 EDT-
1Comments
-
Read later
For the week ending November 4, 2011 we discuss the following top cardiology news from heartwire:
- Fat, unfit, unmotivated: Cardiologist, heal thyself
- BP meds more effective when taken at night
- FDA advisors recommend Vytorin for CVD prevention in predialysis CKD patients
- Fludrocortisone flops for vasovagal syncope: POST 2
- Sapien transcatheter valve approved for inoperable aortic-valve disease: FDA
And also, in brief:
- Esomeprazole, but not rosuvastatin, affects clopidogrel post-PCI: SPICE
- Aneurysm stent okayed for patients with small arteries
- Gender does not predict post-PCI mortality
Join us for a comprehensive review of this week's most important cardiology news.
Your comments
|
||||
|
|
|
|||
|
|
|
|||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!












